{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:37:35Z","timestamp":1792291055059,"version":"4.4.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,9]]},"DOI":"10.7759\/cureus.37345","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T01:48:12Z","timestamp":1681091292000},"source":"Crossref","is-referenced-by-count":4,"title":["Trends and Complication Rates in Ulcerative Colitis Patients With and Without Helicobacter pylori Infections"],"prefix":"10.7759","author":[{"given":"Aaron","family":"Kahlam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayham","family":"Khrais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Khalessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Ahlawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Ulcerative colitis","volume":"87","author":"Adams SM","year":"2013","unstructured":"Adams SM, Bornemann PH. Ulcerative colitis. Am Fam Physician. 2013, 87:699-705.","journal-title":"Am Fam Physician"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60150-0","article-title":"Ulcerative colitis","volume":"380","author":"Ordas I","year":"2012","unstructured":"Ordas I, Eckmann L, Talamini M, et al.. Ulcerative colitis. Lancet. 2012, 380:1606-19. 10.1016\/S0140-6736(12)60150-0","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2020.07.005","article-title":"Epidemiology and pathogenesis of ulcerative colitis","volume":"49","author":"Du L","year":"2020","unstructured":"Du L, Ha C. Epidemiology and pathogenesis of ulcerative colitis. Gastroenterol Clin North Am. 2020, 49:643-54. 10.1016\/j.gtc.2020.07.005","journal-title":"Gastroenterol Clin North Am"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-018-0306-4","article-title":"Gut microbiome structure and metabolic activity in inflammatory bowel disease","volume":"4","author":"Franzosa EA","year":"2019","unstructured":"Franzosa EA, Sirota-Madi A, Avila-Pacheco J, et al.. Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat Microbiol. 2019, 4:293-305. 10.1038\/s41564-018-0306-4","journal-title":"Nat Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.10.029","article-title":"US immigration westernizes the human gut microbiome","volume":"175","author":"Vangay P","year":"2018","unstructured":"Vangay P, Johnson AJ, Ward TL, et al.. US immigration westernizes the human gut microbiome. Cell. 2018, 175:962-972.e10. 10.1016\/j.cell.2018.10.029","journal-title":"Cell"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12165","article-title":"Epidemiology of Helicobacter pylori infection","volume":"19 Suppl 1","author":"Eusebi LH","year":"2014","unstructured":"Eusebi LH, Zagari RM, Bazzoli F. Epidemiology of Helicobacter pylori infection. Helicobacter. 2014, 19 Suppl 1:1-5. 10.1111\/hel.12165","journal-title":"Helicobacter"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-017-1256-4","article-title":"Role of flagella in the pathogenesis of Helicobacter pylori","volume":"74","author":"Gu H","year":"2017","unstructured":"Gu H. Role of flagella in the pathogenesis of Helicobacter pylori. Curr Microbiol. 2017, 74:863-9. 10.1007\/s00284-017-1256-4","journal-title":"Curr Microbiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2011.00874.x","article-title":"Epidemiology of Helicobacter pylori infection and public health implications","volume":"16 Suppl 1","author":"Goh KL","year":"2011","unstructured":"Goh KL, Chan WK, Shiota S, Yamaoka Y. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter. 2011, 16 Suppl 1:1-9. 10.1111\/j.1523-5378.2011.00874.x","journal-title":"Helicobacter"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i21.6374","article-title":"Helicobacter pylori infection and inflammatory bowel disease: is there a link?","volume":"20","author":"Papamichael K","year":"2014","unstructured":"Papamichael K, Konstantopoulos P, Mantzaris GJ. Helicobacter pylori infection and inflammatory bowel disease: is there a link?. World J Gastroenterol. 2014, 20:6374-85. 10.3748\/wjg.v20.i21.6374","journal-title":"World J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15306","article-title":"Systematic review with meta-analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease","volume":"50","author":"Tepler A","year":"2019","unstructured":"Tepler A, Narula N, Peek RM Jr, Patel A, Edelson C, Colombel JF, Shah SC. Systematic review with meta-analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease. Aliment Pharmacol Ther. 2019, 50:121-31. 10.1111\/apt.15306","journal-title":"Aliment Pharmacol Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4166\/kjg.2009.53.6.341","article-title":"[The prevalence of Helicobacter pylori infection in Korean patients with inflammatory bowel disease, a multicenter study]","volume":"53","author":"Song MJ","year":"2009","unstructured":"Song MJ, Park DI, Hwang SJ, et al.. [The prevalence of Helicobacter pylori infection in Korean patients with inflammatory bowel disease, a multicenter study]. Korean J Gastroenterol. 2009, 53:341-7. 10.4166\/kjg.2009.53.6.341","journal-title":"Korean J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2021.62.2.99","article-title":"Incidence and prevalence of inflammatory bowel disease across Asia","volume":"62","author":"Park J","year":"2021","unstructured":"Park J, Cheon JH. Incidence and prevalence of inflammatory bowel disease across Asia. Yonsei Med J. 2021, 62:99-108. 10.3349\/ymj.2021.62.2.99","journal-title":"Yonsei Med J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng SC","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N, et al.. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017, 390:2769-78. 10.1016\/S0140-6736(17)32448-0","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/BF02237231","article-title":"Crohn's disease in Japan: diagnostic criteria and epidemiology","volume":"43","author":"Yao T","year":"2000","unstructured":"Yao T, Matsui T, Hiwatashi N. Crohn's disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum. 2000, 43:S85-93. 10.1007\/BF02237231","journal-title":"Dis Colon Rectum"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI20925","article-title":"Helicobacter pylori persistence: biology and disease","volume":"113","author":"Blaser MJ","year":"2004","unstructured":"Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest. 2004, 113:321-33. 10.1172\/JCI20925","journal-title":"J Clin Invest"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004060","article-title":"Asthma is inversely associated with Helicobacter pylori status in an urban population","volume":"3","author":"Reibman J","year":"2008","unstructured":"Reibman J, Marmor M, Filner J, Fernandez-Beros ME, Rogers L, Perez-Perez GI, Blaser MJ. Asthma is inversely associated with Helicobacter pylori status in an urban population. PLoS One. 2008, 3:e4060. 10.1371\/journal.pone.0004060","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.04619.x","article-title":"Anti-infectious antibodies and autoimmune-associated autoantibodies in patients with type I diabetes mellitus and their close family members","volume":"1173","author":"Krause I","year":"2009","unstructured":"Krause I, Anaya JM, Fraser A, et al.. Anti-infectious antibodies and autoimmune-associated autoantibodies in patients with type I diabetes mellitus and their close family members. Ann N Y Acad Sci. 2009, 1173:633-9. 10.1111\/j.1749-6632.2009.04619.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17962","article-title":"H. pylori attenuates TNBS-induced colitis via increasing mucosal Th2 cells in mice","volume":"8","author":"Wu YZ","year":"2017","unstructured":"Wu YZ, Tan G, Wu F, Zhi FC. H. pylori attenuates TNBS-induced colitis via increasing mucosal Th2 cells in mice. Oncotarget. 2017, 8:73810-6. 10.18632\/oncotarget.17962","journal-title":"Oncotarget"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-019-01022-0","article-title":"H. pylori infection alleviates acute and chronic colitis with the expansion of regulatory B cells in mice","volume":"42","author":"Li X","year":"2019","unstructured":"Li X, Tan J, Zhang F, Xue Q, Wang N, Cong X, Wang J. H. pylori infection alleviates acute and chronic colitis with the expansion of regulatory B cells in mice. Inflammation. 2019, 42:1611-21. 10.1007\/s10753-019-01022-0","journal-title":"Inflammation"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s005350170015","article-title":"Prevalence of Helicobacter pylori infection and correlation between severity of upper gastrointestinal lesions and H. pylori infection in Japanese patients with Crohn's disease","volume":"36","author":"Matsumura M","year":"2001","unstructured":"Matsumura M, Matsui T, Hatakeyama S, et al.. Prevalence of Helicobacter pylori infection and correlation between severity of upper gastrointestinal lesions and H. pylori infection in Japanese patients with Crohn's disease. J Gastroenterol. 2001, 36:740-7. 10.1007\/s005350170015","journal-title":"J Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07434.x","article-title":"The low prevalence of helicobacter infection in patients with inflammatory bowel disease could be attributed to previous antibiotic treatment","volume":"98","author":"Triantafillidis JK","year":"2003","unstructured":"Triantafillidis JK, Gikas A, Apostolidiss N, et al.. The low prevalence of helicobacter infection in patients with inflammatory bowel disease could be attributed to previous antibiotic treatment. Am J Gastroenterol. 2003, 98:1213-4. 10.1111\/j.1572-0241.2003.07434.x","journal-title":"Am J Gastroenterol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.03.024","article-title":"Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics","volume":"126","author":"Sartor RB","year":"2004","unstructured":"Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology. 2004, 126:1620-33. 10.1053\/j.gastro.2004.03.024","journal-title":"Gastroenterology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/1751-2980.12849","article-title":"Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment","volume":"21","author":"Guo XY","year":"2020","unstructured":"Guo XY, Liu XJ, Hao JY. Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment. J Dig Dis. 2020, 21:147-59. 10.1111\/1751-2980.12849","journal-title":"J Dig Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-021-01178-8","article-title":"Microbiota in mesenteric adipose tissue from Crohn's disease promote colitis in mice","volume":"9","author":"He Z","year":"2021","unstructured":"He Z, Wu J, Gong J, et al.. Microbiota in mesenteric adipose tissue from Crohn's disease promote colitis in mice. Microbiome. 2021, 9:228. 10.1186\/s40168-021-01178-8","journal-title":"Microbiome"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.12.014","article-title":"Effects of anti-Helicobacter pylori therapy on incidence of autoimmune diseases, including inflammatory bowel diseases","volume":"17","author":"Lin KD","year":"2019","unstructured":"Lin KD, Chiu GF, Waljee AK, et al.. Effects of anti-Helicobacter pylori therapy on incidence of autoimmune diseases, including inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2019, 17:1991-9. 10.1016\/j.cgh.2018.12.014","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/146354-trends-and-complication-rates-in-ulcerative-colitis-patients-with-and-without-helicobacter-pylori-infections","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:52:18Z","timestamp":1707508338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/146354-trends-and-complication-rates-in-ulcerative-colitis-patients-with-and-without-helicobacter-pylori-infections"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,9]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.37345","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,9]]}}}